Blafar Limited
Desconocido
3D NEONET: Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics
BLAFAR LIMITED
participó en un
H2020:
H2020-MSCA-RISE-2016
Severe ocular disorders are affecting the lives of more than 100Mill people world-wide and at least 25% of the population above 70 years of...
2016-11-08 - 2022-06-30 | Financiado
2016-11-08 - 2022-06-30 | Financiado
MATRIXASSAY: Novel Cell Migration Assay Based on Microtissue Technology and Tissue Specific Matrices
BLAFAR LIMITED
participó en un
H2020:
H2020-MSCA-RISE-2014
Cell migration assays are commonly used to study wound healing, cancer cell invasion, and tissue development. Problems associated with the g...
2015-04-23 - 2019-05-31 | Financiado
2015-04-23 - 2019-05-31 | Financiado
HyMedPoly: Drug Free Antibacterial Hybrid Biopolymers for Medical Applications
BLAFAR LIMITED
participó en un
H2020:
H2020-MSCA-ITN-2014
There is a general consensus that biomedical polymers of natural and synthetic origin should and will play a very important role in the deve...
2014-12-05 - 2018-12-31 | Financiado
2014-12-05 - 2018-12-31 | Financiado
* No se disponen de datos de la empresa actual.